Market Size of Global Sinus Dilation Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 8.80 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Sinus Dilation Devices Market Analysis
The sinus dilation market is expected to register a CAGR of 8.8% during the forecast period of the study.
The COVID-19 pandemic led to interruptions in routine patient care. Many healthcare organizations canceled routine clinic visits and elective surgeries to increase and maintain the availability of intensive care and inpatient care beds and have reorganized medical and nursing staff. This had particularly interrupted care for patients with chronic rhinitis. Also, several adjacent infections were widely reported in COVID-19 infected patients, like fungal sinusitis. For instance, as per the article published in February 2022 in JFMPC, researchers reported that many patients presented with clinical signs and symptoms of fungal infection with a history of COVID-19. This occurred due to the multiple secondary fungal infections because of immune dysregulation, widespread use of steroids, high glycemic index, prolonged hospital stay in intensive care units, and increased ferritin levels. However, with the decreasing number of cases, the long-term impact of the SARS-CoV-2 virus on humans, and large-scale vaccination programs worldwide, the studied market is expected to regain its full growth potential over the forecast period of the study.
The increasing popularity and demand for minimally invasive surgeries owing to their benefits such as smaller incisions, less scarring, high accuracy and decreased risk of complications, shorter hospital stays, and others, coupled with the high burden of sinusitis around the world are expected to be significant growth factors that are fueling growth in the sinus dilation devices market. Further, with the growing number of surgeries and increasing demand for minimally invasive surgical procedures, the demand for sinus dilation products is expected to increase, which will boost growth in the studied market over the forecast period of the study. For instance, in February 2021, Intersect ENT, Inc. launched its new Straight Delivery System packaged with the company's PROPEL Mini (mometasone furoate) Sinus Implant. The combined packaging of the SDS with PROPEL Mini received premarket approval from the FDA. Hence, with the rising number of sinus-related surgeries, the demand for sinus dilation products is expected to increase, which is expected to fuel growth in the studied market.
Thus, due to the rise sinus related issues and the surge in sinus dilation product launches, the studied market is anticipated to grow over the forecast period. However, factors such as risks, complications associated with sinus surgeries, and lack of skilled healthcare professionals are expected to restrain the growth of the sinus dilation devices market during the forecast period.
